Addressing Anemia and Quality of Life Through Current Evidence and Guideline-Based Practice in Lower-Risk Myelodysplastic Syndrome
Podcast 1: Diagnosis and Evaluation
Post-Test/Evaluation
Questions marked with a
*
are required
19%
Contact Information
First Name
Last Name
Email Address
Credentials/Degree (MD, DO, RN, etc.)
Date of Participation
Month
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Day
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Year
2018
2019
2020
2021
2022
2023
2024
2025
While low-risk MDS is diagnosed based on bone marrow biopsy results (blasts, cytogenetics,
molecular studies) as well as labs, on initial patient presentation, which of the following
complaints would be most consistent with early low-risk MDS?
Hemoglobin <10 g/dL and increased bruising/bleeding
Hepatomegaly or splenomegaly
Lymphadenopathy
Weight loss
A 66-year-old woman has dyslipidemia, hypertension, and COPD. She was treated for breast
cancer 2 years ago with chemotherapy, and is currently in remission. She presents with anemia,
and with low red and white cell counts, low platelets, and low hemoglobin levels. Which element
of this patient’s history/presentation would be a warning sign for diagnosis of MDS?
Dyslipidemia
COPD
Hypertension
Recent history of chemotherapy
Start
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close